Every 10-Q that PREAXIA HEALTH CARE PYMNT (PAXH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PAXH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAXH filings page.
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) filed an amended Form 10‑Q/A2 for the quarter ended August 31, 2025, restating its prior 10‑Q and 10‑Q/A after management filed a notice of non‑reliance. The restatement reclassifies three management and consulting contracts from prepaid expenses to warrants, recognizes additional stock issuances and debt conversions, and adjusts related‑party loans and payables.
The company reported no revenue and a net loss of $745,208 for the quarter, driven by $576,134 of operating expenses and a $169,143 loss on debt settlement, compared with a $4,627 loss a year earlier. Extensive equity issuances and conversions increased common shares outstanding to 43,514,782 and improved shareholders’ deficit from $(2,341,169) at May 31, 2025 to $(605,757), while total liabilities fell from $2,341,169 to $736,042. The company discloses substantial doubt about its ability to continue as a going concern, has material weaknesses in disclosure controls, and expects to rely on new capital, related‑party financing and further equity‑based compensation as it develops its healthcare payment and personal finance software.
PreAxia Health Care Payment Systems (PAXH) filed a 10‑Q/A to correct its cover-page share count and a subsequent event. The amendment updates outstanding common shares to 54,314,782 as of October 15, 2025, and notes that 34,547,084 shares were issued to settle prior-quarter stock subscriptions.
For the quarter ended August 31, 2025, PreAxia reported $0 revenue and a net loss of $875,134. Operating expenses were driven by research and development $391,263, management $387,500, and consulting $65,000. Cash was $130,285 with a working capital deficit of $232,678. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
Equity activity included $3,651,222 in stock subscriptions at quarter-end and a $200,000 private placement for 800,000 shares in August, with shares issued in October. Internal controls were deemed not effective as of the quarter end.
PreAxia Health Care Payment Systems Inc. filed its 10‑Q reporting no revenue and a net loss of $875,134 for the three months ended August 31, 2025. Operating expenses were $875,203, driven by research and development $391,263, management and labor $387,500, consulting $65,000, and professional fees $23,200. Basic and diluted loss per share was $(0.04) on a weighted average of 19,767,698 shares.
As of August 31, 2025, cash was $130,285 and working capital deficit was $232,678. Shareholders’ equity was $427,322 with an accumulated deficit of $6,085,524. The company recognized stock subscriptions for services and debt, including $1,800,000 for consulting and management (40% expensed at grant) and $1,643,397 to convert debt. Two related‑party notes were converted on June 30, 2025 at $0.10 per share for 4,668,170 and 10,587,600 shares, and a private placement brought in $200,000 for 800,000 shares in August 2025.
Management disclosed “substantial doubt” about the company’s ability to continue as a going concern and reported disclosure controls and procedures were not effective as of August 31, 2025.